Abstract
The in vitro metabolism of (−)-terpinen-4-ol was examined in human liver microsomes and recombinant enzymes.The biotransformation of (−)-terpinen-4-ol was investigated by gas chromatography–mass spectrometry. (−)-Terpinen-4-ol was found to be oxidized to (−)-(1S,2R,4R)-1,2-epoxy-p-menthan-4-ol, major metabolic product by human liver microsomal P450 enzymes. The formation of metabolites of (−)-terpinen-4-ol was determined by relative abundance of mass fragments and retention times on GC.CYP2A6 in human liver microsomes was a major enzyme involved in the oxidation of (−)-terpinen-4-ol by human liver microsomes, based on the following lines of evidence. First, of 11 recombinant human P450 enzymes tested, CYP2A6 had the highest activity for oxidation of (−)-terpinen-4-ol. Second, oxidation of (−)-terpinen-4-ol was inhibited by (+)-menthofuran. Finally, there was a good correlation between CYP2A6 maker activity and (−)-terpinen-4-ol oxidation activities in liver microsomes of 10 human samples.Kinetic analysis showed that the Vmax/Km values for (−)-(1S,2R,4R)-1,2-epoxy-p-menthan-4-ol catalysed by liver microsomes of human sample HH-18 was 2.49 μL/min/nmol.Human recombinant CYP2A6 catalysed (−)-(1S,2R,4R)-1,2-epoxy-p-menthan-4-ol with Vmax values of 13.9 nmol/min/nmol P450 and apparent Km values of 91 μM.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
